Cargando…
iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine
In the past, several animal disease models were developed to study the molecular mechanism of neurological diseases and discover new therapies, but the lack of equivalent animal models has minimized the success rate. A number of critical issues remain unresolved, such as high costs for developing an...
Autores principales: | Pandey, Shashank, Jirásko, Michal, Lochman, Jan, Chvátal, Alexandr, Chottova Dvorakova, Magdalena, Kučera, Radek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500601/ https://www.ncbi.nlm.nih.gov/pubmed/36143270 http://dx.doi.org/10.3390/jpm12091485 |
Ejemplares similares
-
Role of Peptides in Diagnostics
por: Pandey, Shashank, et al.
Publicado: (2021) -
Animal Models in Diabetic Research—History, Presence, and Future Perspectives
por: Pandey, Shashank, et al.
Publicado: (2023) -
Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM
por: Pandey, Shashank, et al.
Publicado: (2022) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)